GraniteShares YieldBOOST CRCL 

$24.46
8
-$0.57-2.27% Friday 20:00

Statistics

Day High
24.93
Day Low
24.44
52W High
25.92
52W Low
24.44
Volume
11,300
Avg. Volume
-
Mkt Cap
961.55M
P/E Ratio
-
Dividend Yield
5.79%
Dividend
1.42

Upcoming

Dividends

5.79%Dividend Yield
May 26
$0.48
May 26
$0.48
May 26
$0.46
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

9FebExpected
Q2 2020
Q3 2020
Q4 2020
Q1 2021
Q2 2021
Q3 2021
Q4 2021
-0.18
-0.03
0.11
0.26
Expected EPS
-0.1
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow CRY. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. It offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, pulmonary, and general surgical applications; On-X prosthetic aortic and mitral heart valve, and On-X ascending aortic prosthesis; cardiac preservation services; PhotoFix, a bovine pericardial patch; and E-vita OPEN PLUS and E-vita OPEN NEO, a hybrid stent graft system. The company also provides E-xtra DESIGN ENGINEERING products for the treatment of aortic vascular diseases; E-nside, an off-the-shelf stent graft for the treatment of thoraco-abdominal disease; E-vita THORACIC 3G for the endovascular treatment of thoracic aortic aneurysms; E-nya, a thoracic stent graft system for the minimally invasive repair of lesions of the descending aorta; E-ventus BX, a balloon-expandable peripheral stent graft for the endovascular treatment of renal and pelvic arteries; E-liac to treat aneurysmal iliac arteries, and aneurysmal iliac side branches; and E-tegra, an abdominal aortic aneurysms stent graft system. In addition, it offers synthetic vascular grafts for use in open aortic and peripheral vascular surgical procedures; PerClot, an absorbable powdered hemostat for use in surgical procedures; and cardiac laser therapy products, such as SolarGen 2100s Console and SoloGrip III disposable handpieces. Further, the company sells CryoVein femoral vein and CryoArtery femoral artery vascular preservation services; CarbonAid CO2 diffusion catheters and Chord-X ePTFE sutures for mitral chordal replacement; and ascyrus medical dissection stents, as well as offers pyrolytic carbon coating services to other medical device manufacturers. The company serves physicians, hospitals, and other healthcare facilities, as well as cardiac, vascular, thoracic, and general surgeons. The company was formerly known as CryoLife, Inc. and changed its name to Artivion Inc. in January 2022. Artivion Inc. was founded in 1984 and is headquartered in Kennesaw, Georgia.
Show more...
CEO
Employees
1200
Country
United States
ISIN
US38747T6661

Listings

0 Comments

Share your thoughts

FAQ

What is GraniteShares YieldBOOST CRCL stock price today?
The current price of CRY is $24.46 USD — it has decreased by -2.27% in the past 24 hours. Watch GraniteShares YieldBOOST CRCL stock price performance more closely on the chart.
What is GraniteShares YieldBOOST CRCL stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange GraniteShares YieldBOOST CRCL stocks are traded under the ticker CRY.
What is GraniteShares YieldBOOST CRCL market cap?
Today GraniteShares YieldBOOST CRCL has the market capitalization of 961.55M
Does GraniteShares YieldBOOST CRCL pay dividends?
Yes, CRY dividends are paid weekly. The last dividend per share was 0.48 USD. As of today, Dividend Yield (FWD)% is 5.79%.
How many employees does GraniteShares YieldBOOST CRCL have?
As of May 26, 2026, the company has 1,200 employees.
In which sector is GraniteShares YieldBOOST CRCL located?
GraniteShares YieldBOOST CRCL operates in the Other sector.
When did GraniteShares YieldBOOST CRCL complete a stock split?
GraniteShares YieldBOOST CRCL has not had any recent stock splits.